US Medical Devices Ishares ETF (IHI)

After a brutal last week on Trump tariff concerns, Wall Street attempted to bounce back on April 7. Invesco QQQ Trust QQQ added 0.24% in the key trading session and advanced 1.2% after hours. SPDR S&P...

Due to Teleflex’s underperformance relative to its industry peers over the past six months, Wall Street analysts remain cautious about the stock’s prospects.

Teleflex has continued to underperform the broader market over the past several years, yet analysts remain moderately bullish on the stock’s prospects.

STERIS has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

Insulet has outperformed the broader market over the past year, and analysts are highly optimistic about the stock’s prospects.

ResMed has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

MedTech giant Becton, Dickinson and Company underperformed relative to the broader market over the past year, but Wall Street analysts remain upbeat about the stock’s potential.

Despite trailing the broader market over the past year, Zimmer Biomet still holds a moderately favorable outlook among analysts.

Hologic has observed a significant drop in stock prices recently and analysts are taking a more cautious stance on the company’s prospects.

Edwards Lifesciences has underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.